Here are five things to know:
1. Full year net sales were up 9.9 percent to $12.4 billion. Orthopedics sales grew 6.6 percent to $4.7 billion while neurotechnology and spine sales jumped 8.2 percent to $2.1 billion. Medsurg had the biggest growth, at 13.6 percent, reaching $5.5 billion for the year. In the fourth quarter, neurotechnology and spine sales grew the most at 10.3 percent, hitting $586 million.
2. Spine sales over the full year dropped 0.4 percent while neurotechnology jumped 13.4 percent. Knee sales increased 7 percent to $1.6 billion while hip sales remained relatively flat, showing just 1.6 percent growth. The trauma and extremities line increased 8.2 percent to $1.4 billion.
3. The company’s reported net earnings were down 148.9 percent in the fourth quarter, and Stryker reported a $249 million net loss; for the full year, the net loss reached $1 billion with reported earnings decreasing 38.1 percent.
4. Stryker expects 2018 organic sales to grow 6 percent to 6.5 percent.
5. U.S. sales were up 10.1 percent in 2017, hitting $9 billion. International sales also grew 9.4 percent, reaching $3.3 billion.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
